Virpax Pharmaceuticals Overhauls Leadership and Auditor Amid Concerns

Virpax Pharmaceuticals ( (VRPX) ) has shared an announcement.

Virpax Pharmaceuticals, Inc. has experienced significant changes, including the resignation of its auditor, EisnerAmper LLP, and the subsequent appointment of Bush & Associated CPA LLC as the new independent accounting firm. The company’s audit reports for the past two years did not highlight any major issues but did raise concerns about the company’s ongoing viability. Additionally, the Chairman of the Board, Eric Floyd, resigned due to disagreements over the board’s decisions, which he felt could negatively affect the company’s future and the well-being of its key personnel.

For a thorough assessment of VRPX stock, go to TipRanks’ Stock Analysis page.